Skip to main content
Premium Trial:

Request an Annual Quote

Syrrx Gets $2M ATP Grant

NEW YORK, May 3 (GenomeWeb News) - Syrrx announced today that it has received an Advanced Technology Program grant from the National Institute of Standards and Technology to develop nanoscale arrays for improving the crystallization of membrane proteins.

 

The grant is for $2 million over three years, according to the ATP website.

 

The technology that the San Diego-based company hopes to develop with the grant money involves using a regularly-repeating nanoscale pattern to induce crystallization. The company plans to conduct over 100,000 experiments and will subcontract Santa Clara, Calif.-based Parallel Synthesis Technologies to engineer the nanoscale surfaces.

 

The new technology could reduce drug development time and costs, according to Syrrx.

 

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.